Paradigm Biocapital Advisors as of Sept. 30, 2024
Portfolio Holdings for Paradigm Biocapital Advisors
Paradigm Biocapital Advisors holds 31 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Nuvalent Inc-a (NUVL) | 17.3 | $512M | 5.0M | 102.30 | |
| Arcellx Common Stock Call Option (ACLX) | 13.6 | $401M | 4.8M | 83.51 | |
| Argenx Se Sponsored Adr (ARGX) | 8.8 | $260M | 480k | 542.08 | |
| Revolution Medicines (RVMD) | 8.2 | $241M | 5.3M | 45.35 | |
| Crinetics Pharmaceuticals In (CRNX) | 4.4 | $129M | 2.5M | 51.10 | |
| Merus N V (MRUS) | 4.1 | $123M | 2.5M | 49.96 | |
| Janux Therapeutics (JANX) | 3.7 | $109M | 2.4M | 45.43 | |
| Vaxcyte Call Option (PCVX) | 3.5 | $103M | 905k | 114.27 | |
| Kura Oncology (KURA) | 2.9 | $85M | 4.3M | 19.54 | |
| Tarsus Pharmaceuticals (TARS) | 2.7 | $80M | 2.4M | 32.89 | |
| Edgewise Therapeutics (EWTX) | 2.5 | $74M | 2.8M | 26.69 | |
| Disc Medicine (IRON) | 2.5 | $74M | 1.5M | 49.14 | |
| Miragen Therapeutics (VRDN) | 2.2 | $66M | 2.9M | 22.75 | |
| Olema Pharmaceuticals (OLMA) | 2.2 | $66M | 5.5M | 11.94 | |
| Arvinas Ord (ARVN) | 1.9 | $58M | 2.3M | 24.63 | |
| Y Mabs Therapeutics | 1.8 | $54M | 4.1M | 13.15 | |
| Cogent Biosciences (COGT) | 1.7 | $50M | 4.6M | 10.80 | |
| Vera Therapeutics Cl A (VERA) | 1.6 | $49M | 1.1M | 44.20 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 1.6 | $47M | 932k | 50.42 | |
| Beigene Sponsored Adr (ONC) | 1.5 | $45M | 200k | 224.51 | |
| Immatics SHS (IMTX) | 1.5 | $45M | 3.9M | 11.41 | |
| Apogee Therapeutics (APGE) | 1.4 | $41M | 702k | 58.74 | |
| Immunovant (IMVT) | 1.3 | $39M | 1.4M | 28.51 | |
| Cullinan Oncology (CGEM) | 1.3 | $39M | 2.3M | 16.74 | |
| Spyre Therapeutics Com New (SYRE) | 1.3 | $37M | 1.3M | 29.41 | |
| Pliant Therapeutics (PLRX) | 1.2 | $35M | 3.1M | 11.21 | |
| Keros Therapeutics (KROS) | 1.0 | $31M | 525k | 58.07 | |
| Erasca (ERAS) | 1.0 | $29M | 11M | 2.73 | |
| Oruka Therapeutics (ORKA) | 0.6 | $18M | 720k | 24.51 | |
| Perspective Therapeutics Com New (CATX) | 0.4 | $12M | 920k | 13.35 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.2 | $7.3M | 1.2M | 6.30 |
